Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Fröding

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Antimicrobial Agents|June 24, 2025
Susceptibility to new antibiotics and genetic characterisation of carbapenemase-producing Enterobacterales: low activity of cefiderocol against NDM-producing isolatesLisa Faxén, Vilhelm Müller, Margarita Chatzopoulou, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United KingdomChristian G Giske, Inga Fröding, Chowdhury Mehedi Hasan, et al.
Plos One|November 8, 2018
USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016Josefine Enström, Inga Fröding, Christian G Giske, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Emergence and persistent spread of carbapenemase-producing <i>Klebsiella pneumoniae</i> high-risk clones in Greek hospitals, 2013 to 2022Kyriaki Tryfinopoulou, Marius Linkevicius, Olga Pappa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
Defining epidemiological cutoff values for Brucella melitensis: an European multicentre studyFlavia Dematheis, Joseph Papaparaskevas, Erika Matuschek, et al.
The Lancet. Microbe|May 13, 2026
Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance studyInga Fröding, Sophia David, Corin Yeats, et al.
The Lancet. Microbe|May 13, 2026
Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance studySophia David, Anke Kohlenberg, Corin Yeats, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 6, 2024
Genomic analysis of <i>Vibrio cholerae</i> O1 isolates from cholera cases, Europe, 2022Caroline Rouard, David R Greig, Thamida Tauhid, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Antimicrobial Agents|June 24, 2025
Susceptibility to new antibiotics and genetic characterisation of carbapenemase-producing Enterobacterales: low activity of cefiderocol against NDM-producing isolatesLisa Faxén, Vilhelm Müller, Margarita Chatzopoulou, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United KingdomChristian G Giske, Inga Fröding, Chowdhury Mehedi Hasan, et al.
Plos One|November 8, 2018
USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016Josefine Enström, Inga Fröding, Christian G Giske, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Emergence and persistent spread of carbapenemase-producing <i>Klebsiella pneumoniae</i> high-risk clones in Greek hospitals, 2013 to 2022Kyriaki Tryfinopoulou, Marius Linkevicius, Olga Pappa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
Defining epidemiological cutoff values for Brucella melitensis: an European multicentre studyFlavia Dematheis, Joseph Papaparaskevas, Erika Matuschek, et al.
The Lancet. Microbe|May 13, 2026
Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance studyInga Fröding, Sophia David, Corin Yeats, et al.
The Lancet. Microbe|May 13, 2026
Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance studySophia David, Anke Kohlenberg, Corin Yeats, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 6, 2024
Genomic analysis of <i>Vibrio cholerae</i> O1 isolates from cholera cases, Europe, 2022Caroline Rouard, David R Greig, Thamida Tauhid, et al.
Pageof 2